HSPA8P19: A Drug Target / Disease Biomarker (G100420049)

Target Name: HSPA8P19

NCBI ID: G100420049

HSPA8P19

Other Name(s): heat shock protein family A (Hsp70) member pseudogene 19 | Heat shock protein family A (Hsp70) member pseudogene 19

HSPA8P19: A Drug Target / Disease Biomarker

HSPA8P19 is a heat shock protein (HSP) that is expressed in various tissues and cells throughout the body. It is a key protein in the HSP70 family, which is known for its ability to withstand high levels of thermal stress and play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

HSP8P19 is a 19kDa protein that is expressed in various tissues, including muscle, heart, liver, and brain. It is highly conserved across different species, with similar sequences in humans and other organisms. HSP8P19 is a protein that can be used as a drug target or biomarker due to its unique structure and function.

One of the key features of HSP8P19 is its ability to form a disulfide bond, which is a covalent bond formed by the oxidation of a cysteine residue. This disulfide bond allows HSP8P19 to form a stable and highly hydrophilic structure, which is particularly useful in the context of thermal stress.

HSP8P19 plays a key role in the regulation of thermal stress in various organisms. For example, in muscle cells, HSP8P19 is involved in the regulation of protein synthesis and gene expression in response to thermal stress. It has been shown that muscle cells that are exposed to high levels of thermal stress have reduced protein synthesis and gene expression, while HSP8P19 levels are increased to help the cells withstand the stress.

Another function of HSP8P19 is its role in the regulation of cell apoptosis. HSP8P19 has been shown to play a key role in the regulation of cell apoptosis in various tissues. For example, in cancer cells, HSP8P19 has been shown to promote the growth and survival of these cells, while in normal cells it has been shown to play a role in programmed cell death.

HSP8P19 has also been shown to have potential as a biomarker in various diseases. For example, it has been used as a biomarker for cancer, with studies showing that HSP8P19 levels are elevated in various types of cancer. It has also been used as a biomarker for neurodegenerative diseases, with studies showing that HSP8P19 levels are reduced in the brains of individuals with Alzheimer's disease.

Despite its potential as a drug target or biomarker, HSP8P19 has yet to be fully characterized and its functions are not yet fully understood. However, its unique structure and function make it an attractive target for future research.

In conclusion, HSP8P19 is a heat shock protein that is expressed in various tissues and cells throughout the body. It is highly conserved across different species and has been shown to play a key role in the regulation of thermal stress and cell apoptosis. As a result, HSP8P19 is a potential drug target or biomarker that could be useful in the development of new therapies for various diseases. Further research is needed to fully understand its functions and potential uses.

Protein Name: Heat Shock Protein Family A (Hsp70) Member Pseudogene 19

The "HSPA8P19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSPA8P19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets